1,721,065 research outputs found

    Comparative modeling and structure prediction: Application to drug discovery

    Full text link
    Comparative modeling is the most accurate method for protein structure prediction based on the sequence/structure similarities between the unknown protein (target) and a protein with known structure (template)

    Evaluating the relevance of sequence conservation in the prediction of pathogenic missense variants

    No full text
    Evolutionary information is the primary tool for detecting functional conservation in nucleic acid and protein. This information has been extensively used to predict structure, interactions and functions in macromolecules. Pathogenicity prediction models rely on multiple sequence alignment information at different levels. However, most accurate genome-wide variant deleteriousness ranking algorithms consider different features to assess the impact of variants. Here, we analyze three different ways of extracting evolutionary information from sequence alignments in the context of pathogenicity predictions at DNA and protein levels. We showed that protein sequence-based information is slightly more informative in the annotation of Clinvar missense variants than those obtained at the DNA level. Furthermore, to achieve the performance of state-of-the-art methods, such as CADD and REVEL, the conservation of reference and variant, encoded as frequencies of reference/alternate alleles or wild-type/mutant residues, should be included. Our results on a large set of missense variants show that a basic method based on three input features derived from the protein sequence profile performs similarly to the CADD algorithm which uses hundreds of genomic features. As expected, our method results in ~ 3% lower area under the receiver-operating characteristic curve (AUC). When compared with an ensemble-based algorithm (REVEL). Nevertheless, the combination of predictions of multiple methods can help to identify more reliable predictions. These observations indicate that for missense variants, evolutionary information, when properly encoded, plays the primary role in ranking pathogenicity

    RNA structure alignment by a unit-vector approach

    Full text link
    Motivation: The recent discovery of tiny RNA molecules such as μRNAs and small interfering RNA are transforming the view of RNA as a simple information transfer molecule. Similar to proteins, the native three-dimensional structure of RNA determines its biological activity. Therefore, classifying the current structural space is paramount for functionally annotating RNA molecules. The increasing numbers of RNA structures deposited in the PDB requires more accurate, automatic and benchmarked methods for RNA structure comparison. In this article, we introduce a new algorithm for RNA structure alignment based on a unit-vector approach. The algorithm has been implemented in the SARA program, which results in RNA structure pairwise alignments and their statistical significance. Results: The SARA program has been implemented to be of general applicability even when no secondary structure can be calculated from the RNA structures. A benchmark against the ARTS program using a set of 1275 non-redundant pairwise structure alignments results in ∼6% extra alignments with at least 50% structurally superposed nucleotides and base pairs. A first attempt to perform RNA automatic functional annotation based on structure alignments indicates that SARA can correctly assign the deepest SCOR classification to > 60% of the query structures. © The Author 2008. Published by Oxford University Press. All rights reserved

    ContrastRank: A new method for ranking putative cancer driver genes and classification of tumor samples

    Full text link
    Motivation: The recent advance in high-throughput sequencing technologies is generating a huge amount of data that are becoming an important resource for deciphering the genotype underlying a given phenotype. Genome sequencing has been extensively applied to the study of the cancer genomes. Although a few methods have been already proposed for the detection of cancer-related genes, their automatic identification is still a challenging task. Using the genomic data made available by The Cancer Genome Atlas Consortium (TCGA), we propose a new prioritization approach based on the analysis of the distribution of putative deleterious variants in a large cohort of cancer samples. Results: In this paper, we present ContastRank, a new method for the prioritization of putative impaired genes in cancer. The method is based on the comparison of the putative defective rate of each gene in tumor versus normal and 1000 genome samples. We show that the method is able to provide a ranked list of putative impaired genes for colon, lung and prostate adenocarcinomas. The list significantly overlaps with the list of known cancer driver genes previously published. More importantly, by using our scoring approach, we can successfully discriminate between TCGA normal and tumor samples. A binary classifier based on ContrastRank score reaches an overall accuracy490% and the area under the curve (AUC) of receiver operating characteristics (ROC)>0.95 for all the three types of adenocarcinoma analyzed in this paper. In addition, using ContrastRank score, we are able to discriminate the three tumor types with a minimum overall accuracy of 77% and AUC of 0.83. Conclusions: We describe ContrastRank, a method for prioritizing putative impaired genes in cancer. The method is based on the comparison of exome sequencing data from different cohorts and can detect putative cancer driver genes. ContrastRank can also be used to estimate a global score for an individual genome about the risk of adenocarcinoma based on the genetic variants information from a whole-exome VCF (Variant Calling Format) file. We believe that the application of ContrastRank can be an important step in genomic medicine to enable genome-based diagnosis. © The Author 2014. Published by Oxford University Press. All rights reserved

    Computational and Theoretical Methods for Protein Folding

    Full text link
    A computational approach is essential whenever the complexity of the process under study is such that direct theoretical or experimental approaches are not viable. This is the case for protein folding, for which a significant amount of data are being collected. This paper reports on the essential role of in silico methods and the unprecedented interplay of computational and theoretical approaches, which is a defining point of the interdisciplinary investigations of the protein folding process. Besides giving an overview of the available computational methods and tools, we argue that computation plays not merely an ancillary role but has a more constructive function in that computational work may precede theory and experiments. More precisely, computation can provide the primary conceptual clues to inspire subsequent theoretical and experimental work even in a case where no preexisting evidence or theoretical frameworks are available. This is cogently manifested in the application of machine learning methods to come to grips with the folding dynamics. These close relationships suggested complementing the review of computational methods within the appropriate theoretical context to provide a self-contained outlook of the basic concepts that have converged into a unified description of folding and have grown in a synergic relationship with their computational counterpart. Finally, the advantages and limitations of current computational methodologies are discussed to show how the smart analysis of large amounts of data and the development of more effective algorithms can improve our understanding of protein folding

    Comparative Modeling: The State of the Art and Protein Drug Target Structure Prediction

    Full text link
    The goal of computational protein structure prediction is to provide three-dimensional (3D) structures with resolution comparable to experimental results. Comparative modeling, which predicts the 3D structure of a protein based on its sequence similarity to homologous structures, is the most accurate computational method for structure prediction. In the last two decades, significant progress has been made on comparative modeling methods. Using the large number of protein structures deposited in the Protein Data Bank (∼65,000), automatic prediction pipelines are generating a tremendous number of models (∼1.9 million) for sequences whose structures have not been experimentally determined. Accurate models are suitable for a wide range of applications, such as prediction of protein binding sites, prediction of the effect of protein mutations, and structure-guided virtual screening. In particular, comparative modeling has enabled structure-based drug design against protein targets with unknown structures. In this review, we describe the theoretical basis of comparative modeling, the available automatic methods and databases, and the algorithms to evaluate the accuracy of predicted structures. Finally, we discuss relevant applications in the prediction of important drug target proteins, focusing on the G protein-coupled receptor (GPCR) and protein kinase families
    corecore